Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Olimpia Iacono

Insulin/Carbohydrates Ratio During the First 6‐month Therapy With Insulin Degludec in a Paediatric Population With Type 1 Diabetes Previously Treated With Insulin Glargine. An Observational Longitudinal Study

Endocrinology, Diabetes & Metabolism
2020English

Related publications

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Fasting and Insulin Glargine in Individuals With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Dose Titration and Glycemic Control With Insulin Glargine 100 U/Ml in Previously Uncontrolled Patients With Type 2 Diabetes: A 6-Month Prospective Observational Study in Primary Care in Lebanon.

International Journal of Advanced Research
2019English

Effects of Insulin Degludec and Insulin Glargine on Day-To-Day Fasting Plasma Glucose Variability in Individuals With Type 1 Diabetes: A Multicentre, Randomised, Crossover Study

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin

Journal of Medical Economics
Health Policy
2017English

Cost Analysis of Insulin Degludec in Comparison With Insulin Glargine U100 in the Treatment of Type 1 Diabetes Mellitus in the Brazilian Private Health Care System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Observational Study of the Use of Insulin Glargine as Basal Therapy in Patients With Type 2 Diabetes Mellitus in Morocco

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy